CPI-0610 Demonstrates Activity in Patients With Myelofibrosis After Ruxolitinib Failure

Forum rules
Post Reply
User avatar
socrates_8
Posts: 28
Joined: Tue Apr 23, 2019 11:34 am

CPI-0610 Demonstrates Activity in Patients With Myelofibrosis After Ruxolitinib Failure

Post by socrates_8 »

CPI-0610 Demonstrates Activity in Patients With Myelofibrosis After Ruxolitinib Failure
Marina Kremyanskaya, MD, PhD
Published Online:5:25 PM, Wed July 31, 2019


Morning all wherever you might be located... :-)

Here is a short article about a new drug for MF patients:



Article:

https://www.targetedonc.com/videos/cpi0 ... gfmXeoKT5Y

Hopefully we will learn more as these trials continue but it does look promising thus far...

Best wishes

Steve
Top
mocha38
Posts: 2
Joined: Sat Aug 17, 2019 2:02 pm

Re: CPI-0610 Demonstrates Activity in Patients With Myelofibrosis After Ruxolitinib Failure

Post by mocha38 »

Great news! Just wondering if this would work for someone who is Jak2 -ve ?
Top
User avatar
MPN-MATE Admin
Site Admin
Posts: 547
Joined: Mon Apr 22, 2019 11:38 pm

Re: CPI-0610 Demonstrates Activity in Patients With Myelofibrosis After Ruxolitinib Failure

Post by MPN-MATE Admin »

Hey Mocha... :-)

I don't see why not(?)

With what & when were you diagnosed Mocha?

I am Post ET/MF. I was diagnosed 3 years ago, & my platelets are always staying way to high at the present (c. 900s), even though I am already on Ruxolitinib... December this year, it will be three (3) years on Ruxolitinib.

My Driver Mutation is CALR Type2, & I also have another High Risk (HR) mutation called ASXL1+... Am also just a tad concerned about having another TIA (minor brain stroke) too... Had two already ...

Hence, anything that might be a new treatment regime for me is of great interest... :-)

Steve
Top
Post Reply

Return to “MATEs FORUM”